Long-Term Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan- or Busulfan-Based Conditioning in Pediatric Patients with Acute Leukemia or Myelodysplastic Syndrome: Results of an Associazione Italiana Ematologia Oncologia Pediatrica Retrospective Study
Patients undergoing hematopoietic stem cell transplantation (HSCT) for hematologic malignancies during childhood have an increased risk of developing long-term sequelae that are in part attributable to the conditioning regimen. The present study aimed to assess the occurrence of long-term toxicities in a population of children who underwent HSCT for hematologic malignancies using either treosulfan or busulfan in the conditioning regimen. The cumulative incidences of growth impairment, altered gonadal function, altered thyroid function, cataracts, secondary malignant neoplasia, and altered pulmonary function were evaluated retrospectively by univariable and multivariable analyses in a population of 521 pediatric patients with acute leukemias or myelodysplastic syndromes treated in 20 Italian transplant centers affiliated with the Associazione Italiana Ematologia ed Oncologia Pediatrica (AIEOP).
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Francesco Saglio, Daria Pagliara, Marco Zecca, Adriana Balduzzi, Alessandro Cattoni, Arcangelo Prete, Francesco Paolo Tambaro, Maura Faraci, Elisabetta Calore, Franco Locatelli, Franca Fagioli, AIEOP BMT Group Tags: Full Length Article Source Type: research
More News: Acute Leukemia | Biology | Cancer & Oncology | Cataracts | Children | Hematology | Italy Health | Leukemia | Myelodysplastic Syndrome | Pediatrics | Stem Cell Therapy | Stem Cells | Study | Thyroid | Toxicology | Transplants